# XyloCor Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xylocor-therapeutics

- Industry: Biotechnology
- Headquarters: Wayne, US
- Website: www.xylocor.com
- Total disclosed funding: $69M
- Latest round: Series B (Dec 6, 2024)
- Investors on record: 7

## About

Founded in 2013 and based in Pennsylvania, US, XyloCor Therapeutics, Inc. is a biopharmaceutical company that develops gene therapy for people with cardiovascular disease. Ronald Crystal and Todd Rosengart are the co-founders of the company. In January 2024, XyloCor Therapeutics, Inc. raised USD 67.5 million in series B funding led by new investor Jeito Capital, with participation from returning investors EQT, Fountain Healthcare Partners, and Lumira Ventures.
 

XyloCor's lead gene therapy product, XC001, is for individuals who have an inadequate endogenous self-revascularization response to ischemia. The XC001 and its prototype formulations are capable of robustly enhancing the blood supply to ischemic tissues in animal models and in clinical testing. The firm's secondary product, XC002, is for patients with cardiac tissue damage from heart attacks.

The company will use the funding to support two Phase 2b clinical trials of XC001, one for refractory angina using a new non-surgical endocardial injection method, and another as an adjunctive treatment to coronary artery bypass graft surgery.

## Funding rounds

- Series B, Dec 6, 2024, $30M — EQT, Fountain Healthcare Partners, Jeito Capital, Lumira Ventures
- Series A, Mar 22, 2021, $23M — Sofinnova Investments, EQT Life Sciences, Fountain Healthcare Partners, Longwood Fund, Lumira Ventures
- Series A, Dec 6, 2018, $17M — Sofinnova Investments, EQT Life Sciences

## Investors

- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series A
- Fountain Healthcare Partners (https://capitalatlas.ai/funds/fountain-healthcare-partners) — Series A, Series B
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Series A
- Lumira Ventures (https://capitalatlas.ai/funds/lumira-ventures) — Series A, Series B
- EQT (https://capitalatlas.ai/funds/eqt) — Series B
- Jeito Capital (https://capitalatlas.ai/funds/jeito-capital) — Series B